Report updated Apr 24, 2026

Overview · Full Intel report in progress

Antibiothérapie Pédiatrique is an established medical app that is completely free.

What is Antibiothérapie Pédiatrique?

Antibiothérapie Pédiatrique is a medical reference tool developed by the CHU Sainte-Justine team to assist clinicians with anti-infective selection and pediatric dosing. The app provides treatment strategies based on the institution's 22 years of clinical experience and local epidemiological data.

Current Momentum

v2.3 · 3w ago

Intense

Last updated 26d ago. 5 versions tracked.

AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Competition

Rivals identification in progress

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

MedicalGrossing

Rating Pulse 🇺🇸

Gathering signals...

What makes this app unique?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Anti-infective SelectionStandard

Provides guidance on choosing appropriate anti-infective agents for pediatric patients.

Dosing SupportStandard

Offers specific dosage recommendations tailored to the pediatric population.

Clinical Reference SectionsStandard

Organizes content into three main sections, including general information on medical subjects.

How much does it cost?

Free

Who Built It?

Messil

(1)

Equipping junior medical residents with concise clinical reference tools to navigate high-pressure on-call shifts and pediatric dosing.

Portfolio

3

Apps

Paid 2
Medical100%

Who is Messil?

Messil inc. has established a distinct position by translating practitioner-led insights and institutional clinical protocols into specialized mobile reference tools. Their moat is built on the integration of localized data—such as Quebec-specific surgical notes and institutional pediatric dosing strategies—which provides a level of regional utility that generic medical references lack. The publisher maintains a high-intensity update cadence, signaling a strategic commitment to clinical accuracy over portfolio expansion.

Who is Messil for?

  • Junior medical residents
  • Interns
  • Medical students
  • Particularly those in surgical or pediatric rotations requiring rapid clinical guidance
Intense

Portfolio momentum

The publisher is highly active, having released 11 updates across its 3-app portfolio in the last 6 months to ensure clinical data remains current.

Last release · 26d agoActive apps · 3

Analysis in progress, available soon

What do users think recently?

Analysis in progress, available soon

Analysis in progress, available soon

What is the competitive landscape for Antibiothérapie Pédiatrique?

How's The Medical Market?

Market outlook for this category

Available very soon

Strategic analysis coming soon

SWOT, key takeaways & outlook

The outtake for Antibiothérapie Pédiatrique

Key Takeaways

The app serves as a localized clinical decision support tool reflecting the specific treatment protocols and experience of the CHU Sainte-Justine infectious disease department.

Where Is It Heading?

Trend analysis

Available very soon

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by Antibiothérapie Pédiatrique, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

No changes detected yet.

Cite this report

Marlvel.ai. “Antibiothérapie Pédiatrique Intelligence Report.” Updated Apr 24, 2026. https://marlvel.ai/intel-report/medical/antibiotherapie-pediatrique

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0